DENISE K. VOWELL, Special Master.
On February 14, 2014, petitioners filed a motion requesting that "their names, the minor child's initials,[
Respondent filed her response on February 27, 2014, indicating she "takes no position on petitioners' motion." Respondent's Response to Pet. Motion at 2.
In spite of the provisions of § 12(d)(4)(B) of the Vaccine Act,
Section 12(d)(4)
Under § 12(d)(4)(A), information may not be disclosed without the written consent of the party who submitted the information. Thus, Congress protected any information submitted by a party from public view, effectively sealing pre-decisional Vaccine Act proceedings.
However, Congress required disclosure of vaccine decisions, while allowing the parties to seek redaction of specified types of information. § 12(d)(4)(B).
Obviously, there is tension in § 12(d)(4). On one hand, the statute provides that information submitted by a party is completely protected from disclosure to third parties, absent the written consent of the party providing it. § 12(d)(4)(A). On the other hand, the statute requires decisions
In enacting § 12(d)(4), Congress struck a different balance between privacy interests pre- and post-decision. Everything, without exception, is protected pre-decisionally, absent consent to disclose. Post-decisionally, however, disclosure is the default setting for decisions of the special masters, unless the party objecting to disclosure can demonstrate that the information is both the type for which protection is provided
Three years after the addition of § 12(d)(4)(B), Congress enacted the E-Government Act of 2002
Because of privacy and security concerns associated with this increased public access, Congress instructed the Supreme Court to "prescribe rules" to address these concerns. E-Government Act § 205(c)(3). In response, the federal courts adopted Federal Rule of Civil Procedure ["FRCP"] 5.2. Approximately a year later, the United States Court of Federal Claims incorporated FRCP 5.2, minus subsection c (which deals with Social Security appeals and Immigration cases), into its Rule 5.2.
In accordance with Vaccine Rule 16(b) and the heightened privacy concerns for minors, I recently ordered, sua sponte, the amending of captions in cases assigned to me to reflect only the initials of any minor. This case was one of those in which I ordered the caption changed. See Order, issued Dec. 11, 2013. I am similarly ordering the redaction of the minor child's birthdate in this order. Thus, my ruling already contains only the initials of the minor child and will be redacted to reflect only the year for the minor child's birthdate.
Petitioners insist that the replacement of their child's name with her initials is not sufficient to protect her privacy due to information already a part of the public record or known by those in their community. Pet. Motion at 3. Petitioners therefore request that
As support for their request, petitioners cite to decisions which exempt identifying information from the disclosure requirements of the Freedom of Information Act (FOIA).
Petitioners indicate their request is motivated by a desire to protect their family's privacy but "is based primarily on their substantial need to protect the privacy of their minor child." Pet. Motion at 2. Petitioners assert their minor child "has a substantial interest in maintaining the privacy of her medical and educational information" (id. at 2-3) and claim that its disclosure "would cause irreparable damage to [their] minor child" (id. at 4). Other than maintaining the information is "personal" and "private" (id. at 2, 5), petitioners do not explain how or why its disclosure would harm their child.
Regarding their request to redact the names of healthcare and other service providers, petitioners expressed concern about the effect disclosure would have on the relationship with service providers and care received by their child. Petitioners argue that disclosure would "violat[e] and impair[] the providers' confidential relationship" and "could be deleterious to the professional efforts and involvement of the providers." Pet. Motion at 6. Again, petitioners failed to expound on the specific harm they anticipate. I note that the vast majority of special masters' decisions reflect the names of treating physicians, and that no evidence of negative effects on doctor-patient relationships has been proffered. I also note that one of the educators whose name was included in the redaction request testified at the fact hearing in this case.
Petitioners argue that redaction of this information is appropriate under § 12(d)(4)(B)(ii). I disagree.
Petitioners' argument suffers from the same flaw as the argument of petitioners in several recently decided cases.
The disclosure scheme that petitioners propose is not the disclosure scheme that Congress devised. Although Congress protected information submitted during vaccine proceedings (§ 12(d)(4)(A)), it specifically instructed that decisions in vaccine cases be disclosed (§ 12(d)(4)(B)). In directing special masters to include both findings of fact and conclusions of law in their decisions (§ 12(d)(3)(A)), Congress must have understood that these decisions would contain personal and medical information. Instead of giving petitioners the right to demand redaction of information they wish to keep private, Congress permitted redaction only in the limited circumstances set forth in §§ 12(d)(4)(B)(i) and (ii).
The Congressional mandate to disclose decisions in vaccine cases is reflective of the common law right favoring public access to judicial records and proceedings. See Langland, 2011 WL 802695, at *7 (citing Nixon v. Warner Commc'ns, Inc., 435 U.S. 589, 598-99 (1978)). This common law right "is essential to the preservation of our system of self-government." Miller-Holzwarch, Inc. v. United States, 44 Fed. Cl. 153, 154 (1999).
Given the choice, most litigants would prefer to keep their personal information private. However, to overcome the presumption for public access, a petitioner must establish a compelling reason, tailored to meet the individual interest it serves. Langland, 2011 WL 802695, at *7-8.
Disclosure of vaccine decisions also serves the Vaccine Act's goals of providing quick, easy, certain, and generous compensation to vaccine-injured persons, improving vaccine safety, and imparting to the public accurate information involving the risks and safety of vaccines. See H.R. REP. No. 99-908, at 3-7 (1986), reprinted in 1986 U.S.C.C.A.N. 6344, 6344-48. "As Congress recognized, the public needs to know whether, when, and in what circumstances vaccines are determined to cause injuries." Langland, 2011 WL 802695, at *9.
While it is true that redacting information such as petitioners' names would not impact the public's access to other more relevant information, doing so is not in keeping with the system Congress devised in § 12(d)(4)(B). The fact that Congress specifically required notice that vaccine petitions had been filed demonstrates that it did not intend petitioners in these proceedings to be anonymous. See § 12(b)(2). In § 25 of the Vaccine Act, Congress addressed concerns about disclosure of information provided to HHS, not judicial decisions, and expressly prohibited the release of identifying information in response to FOIA requests. § 25(c)(1). Congress could have included a similar prohibition in §§ 12(b)(2), 12(d)(3), and 12(d)(4)(B) but did not. Clearly, Congress did not envision a system where petitioners' right to privacy was absolute.
Petitioners ask that I deviate from the system created by Congress and grant them complete privacy by ensuring they remain anonymous but, as the special master in Langland concluded, "[n]o statute, rule, or decision supports [p]etitioners' request for total anonymity." 2011 WL 802695, at *1. Congress did not create a totally private (anonymous) system to adjudicate vaccine claims. Castagna, 2011 WL 4348135, at *1, 11.
As a special master, my authority originates from the Vaccine Act. Patton v. Sec'y, HHS, 25 F.3d 1021, 1027 (Fed. Cir. 1994). Thus, I have "no inherent authority to order redaction of private information." Langland, 2011 WL 802695, at *2. Having already amended the caption to reflect the minor's initials and now ordering the redaction of the minor child's birthdate in accordance with RCFC 5.2(a)(2) and the E-Government Act, I intend any future action to comport with the requirements of § 12(d)(4)(B)(ii).
Before redaction is appropriate under § 12(d)(4)(B)(ii), the information to be redacted must be shown to "constitute a clearly unwarranted invasion of privacy." Because this language mirrors that found in one of the exemptions to the disclosure requirements under FOIA (known as exemption 6),
Petitioners cited to Long, 778 F.Supp.2d 222, a case involving Vaccine Program information determined to meet the requirements of exemption 6 (disclosure would constitute a clearly unwarranted invasion of privacy) and argue that I should reach a similar conclusion in this case. Pet. Motion at 8-13. I disagree and find that it is not appropriate to apply the same analysis used in FOIA cases to determine if redaction of information in vaccine decisions is justified. Additionally, I conclude that petitioners have not established that disclosure of the information they seek to redact would constitute a clearly unwarranted invasion of privacy under § 12(d)(4)(B)(ii).
When deciding whether the disclosure of information about an individual would constitute a clearly unwarranted invasion of privacy in FOIA cases, courts have balanced the individual's privacy rights against FOIA's purpose — increasing the transparency of government actions. See, e.g., Dep't of the Air Force v. Rose, 425 U.S. 352 (1976) (discussing Congress's intent in crafting this exemption). Although the similarities in language suggest a similar balancing act be employed for § 12(d)(4)(B)(ii) of the Vaccine Act, there are a number of differences between the two branches of government involved and the common law applying to each. See Castagna, 2011 WL 4348135, at *15 (warning that despite similarity in language, parallels should not be drawn when the statutes involved lack a common purpose and relate to different people and entities).
What constitutes a clearly unwarranted invasion of personal privacy under FOIA's exemption 6 has little applicability in determining if disclosure of a judicial decision would result in a clearly unwarranted invasion of privacy under § 12(d)(4)(B)(ii) of the Vaccine Act. Most significantly, there is a common law right of public access to judicial decisions (In re Violation of Rule 28(D), 635 F.3d 1352, 1356 (Fed. Cir. 2011) (citing Nixon, 435 U.S. at 597-99)) but there is no common law right of public access to information held by government agencies. The enactment of FOIA provided a statutory right, tempered by various exceptions.
The two statutes have different aims and purposes. While FOIA mandates disclosure of information in an effort to produce open and transparent government, the Vaccine Act addresses concerns as diverse as ensuring an adequate supply of vaccines by protecting vaccine manufacturers from burdensome litigation, providing those injured by vaccines a no-fault, streamlined alternative to costly tort litigation, and improving public confidence in vaccine safety. The disclosure requirement found in § 12(d)(4)(B) serves each of these functions. The disclosure requirement provides information to the public about vaccines, their side effects, and their general safety.
A FOIA plaintiff seeks disclosure from the government. When the government opposes such disclosure under exemption 6, it stands in the shoes of the individual whose privacy interests are at stake. It must establish that the disclosure would constitute a clearly unwarranted invasion of that person's personal privacy. In contrast, a tort plaintiff or Vaccine Act petitioner places his or her own medical condition and other personal information in issue when a claim is filed. Rather than seeking information about a third party to improve government transparency, a Vaccine Act petitioner who seeks redaction (and particularly one who seeks such sweeping redactions as are requested here) seeks to lock the window, drop the blinds, and draw the curtain to impede the transparency of the judicial process, thwarting the aims of the Act as well as its plain language.
In FOIA cases, the government agency opposing disclosure due to exemption 6 has the substantial burden of establishing that the information should be exempted from disclosure. "[E]xemptions from disclosure must be narrowly construed." Morley v. CIA, 508 F.3d 1108, 1114-15 (D.C. Cir. 2007) (citing Vaughan v. Rosen, 484 F.2d 820, 823, 828 (D.C. Cir. 1973)). In vaccine cases, petitioners are seeking an exception to the general mandate to disclose. Petitioners who want information redacted must establish disclosure would constitute a clearly unwarranted invasion of privacy.
Finally, the type of information involved is different. In FOIA cases, plaintiffs seek information regarding the operation of government agencies which may include the personal information of a third party
As support for their position, petitioners point to Long, 778 F.Supp.2d 222. In Long, the plaintiffs filed a request for information under FOIA. They sought information from the Department of Justice's ["DOJ's"] Civil Division case management system database (CASES) regarding the vaccinations involved in claims filed under the Vaccine Act. Id. at 224. In particular, plaintiffs asked for the type of vaccines involved in these claims and date the vaccines were administered.
At first, thinking this information originated from the Vaccine Adverse Events Reporting System (VAERS), DOJ argued that § 25 of the Vaccine Act prohibited its disclosure. DOJ's argument was deemed to be insufficient and the release of the information was ordered. Long, 778 F. Supp. 2d at 225-26. When seeking reconsideration of the court's decision, the government's attorney realized the information was gathered from petitions filed in the Vaccine Program and was, thus, protected from disclosure under § 12(d)(4)(A) and FOIA's exemption 3 (§ 552(b)(3)). Id. at 227-28. The judge in Long accepted that argument. In addition, the court held that the information also was protected under FOIA's exemption 6 (§ 552(b)(6)). Id. at 236.
Petitioners argue that I should apply the same analysis to this case and similarly find the information should not be disclosed. Petitioners' argument is not persuasive.
In addition to the differences between Vaccine Act cases and cases involving FOIA's exemption 6 which were discussed in Part 2.a., there are several important distinctions between Long and the instant case.
Rather than seeking protection of their personal information under statutory provisions in the Vaccine Act, the plaintiffs in Long requested other individuals' vaccine information under FOIA. The information they sought was not contained in vaccine decisions,
In their motion for redaction, petitioners failed to recognize this distinction. Like the special master in House, 2012 WL 402040, at *6, I agree with and adopt the reasoning in Castagna, 2011 WL 4348135, at *19.
Although the judge's ruling regarding exemption 3 would have been sufficient to reject the plantiffs' request in Long, the judge extended his analysis to cover exemption 6 as well. Long, 778 F. Supp. 2d at 234-35. Even though I have held the analysis regarding FOIA's exemption 6 is not relevant in § 12(d)(4)(B)(ii) analyses, petitioners further weaken their argument by misinterpreting Long's finding with regard to exemption 6. Petitioners suggest that the outcome in Long shows the importance which should be attached to this type of information. Pet. Motion at 12-13.
However, the precise holding in Long does not support that view. In Long, the judge reached his decision
Although petitioners argue their minor child and family will be damaged by the release of the medical and educational information in my ruling, they have failed to provide any specific reasons that the information (already known to many third parties) would damage their child. Petitioners' minor child suffers from several medical conditions, some present since birth, and some which developed over time. Believing the influenza vaccine she received when almost six years old caused or significantly aggravated at least one of her illnesses, petitioners filed this claim.
Petitioners have not demonstrated that there is anything in the ruling which would affect the care petitioners' child is receiving or that would subject her to ridicule. Such speculative harm is not sufficient to justify redaction under § 12(d)(4)(B)(ii). Congress determined that Vaccine Act decisions, like other judicial decisions, should be publicly available. Given the nature of the cases expected to be filed under this new Act, Congress was certainly aware that medical records containing information regarding a petitioner's health, prognosis, treatment, etc., would be a large part of such decisions. Nevertheless, they explicitly provided for disclosure of Vaccine Act decisions. Congress could have provided the anonymity petitioners seek. It did not. It could have protected all medical information from disclosure. It did not.
Petitioners have not shown that disclosure of the information they seek to redact in my ruling would constitute a clearly unwarranted invasion of privacy under § 12(d)(4)(B)(ii).
Although petitioners did not request redaction of the minor child's birthdate, RCFC 5.2(a)(2) and the E-Government Act clearly authorize me to do so. Thus, in the interest of protecting the privacy of the minor child, I am ordering, sua sponte, this redaction.